The Safety and Effectiveness of Lamivudine Plus Stavudine or Zidovudine in HIV-Infected Patients Who Have Taken Zidovudine
Status:
Completed
Trial end date:
1997-12-01
Target enrollment:
Participant gender:
Summary
To compare the magnitude and durability of the reduction in plasma HIV RNA in the two
treatment groups over the first 12 weeks of treatment. To determine the safety of each of the
two treatment groups.